Lilly, Novo Nordisk’s Weight-Loss Drugs

At a scientific conference beginning Friday, Eli Lilly and Novo Nordisk will show off their next-generation weight-loss drugs. Wall Street—and Hollywood—are already mad for their existing weight-loss products. In the next few days, the pharma rivals will present early data on drugs that could prove more powerful.

Shares of Lilly (ticker: LLY) and Novo (NOVO) have ridden wild demand for a new class of drugs called incretins, that allow patients to lose 15% to 20% of their body weight. At a recent $453, Lilly stock trades at an eye-watering 50 times this year’s earnings forecast, while Novo stock goes for 30 times earnings, at $160.

AI Art generators

Artificial intelligence (AI) is not only affecting industries like business and healthcare. It is also playing an increasing role in the creative industries by ushering in a new era of AI-generated art. AI technologies and tools are often widely accessible to anyone, which is helping to create an entirely new generation of artists. 

Let’s take a look at the 10 best AI art generators: